Cargando…

Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia

Schizophrenia patients with an earlier age of onset have been found to have more serious negative symptoms and cognitive deficits. Oxidative stress is thought to be implicated in cognitive impairment in schizophrenia. Total antioxidant capacity (TAOC) is an essential indicator of oxidative stress. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiaxin, Li, Deyang, Guo, Junru, Wang, Dongmei, Zhang, Xiangyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295646/ https://www.ncbi.nlm.nih.gov/pubmed/37371989 http://dx.doi.org/10.3390/antiox12061259

Ejemplares similares

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2022)

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021)

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
por: Guo, Huagui, et al.
Publicado: (2023)

PM505. Impaired glucose tolerance, symptoms and cognitive deficits in first-episode drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Association of Transferrin Gene Polymorphism with Cognitive Deficits and Psychiatric Symptoms in Patients with Chronic Schizophrenia
por: Chen, Pinhong, et al.
Publicado: (2022)

Decreased Resting-State Interhemispheric Functional Connectivity Correlated with Neurocognitive Deficits in Drug-Naive First-Episode Adolescent-Onset Schizophrenia
por: Liu, Yi, et al.
Publicado: (2017)

Evaluation of antioxidant deficit in schizophrenia
por: Dadheech, Gora, et al.
Publicado: (2008)

Sensory Gating Deficits and their Clinical Correlates in Drug-Free/Drug-Naive Patients with Schizophrenia
por: Karkal, Ravichandra, et al.
Publicado: (2018)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia
por: Zahedi Avval, Farnaz, et al.
Publicado: (2018)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
por: Wang, Keqiang, et al.
Publicado: (2022)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Disassociated and concurrent structural and functional abnormalities in the drug-naïve first-episode early onset schizophrenia
por: Li, Qiang, et al.
Publicado: (2022)

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia
por: Yang, Mi, et al.
Publicado: (2020)

Cognitive deficits in familial schizophrenia
por: Saha, Aneek, et al.
Publicado: (2021)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Antioxidant treatment ameliorates prefrontal hypomyelination and cognitive deficits in a rat model of schizophrenia
por: Maas, D. A., et al.
Publicado: (2021)

Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study
por: Wu, Zhiwei, et al.
Publicado: (2021)

Cognitive deficits and functional outcome in schizophrenia
por: Bowie, Christopher R, et al.
Publicado: (2006)

Dynamic Alterations of Amplitude of Low-Frequency Fluctuations in Patients With Drug-Naïve First-Episode Early Onset Schizophrenia
por: Li, Qiang, et al.
Publicado: (2020)

Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia
por: Plichta, Piotr, et al.
Publicado: (2023)

Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia
por: Yang, Mi, et al.
Publicado: (2022)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

Multimodal brain deficits shared in early‐onset and adult‐onset schizophrenia predict positive symptoms regardless of illness stage
por: Feng, Aichen, et al.
Publicado: (2022)

Are Executive Functions Deficits in Early-Onset Chronic Schizophrenia More Severe than in Adult-Onset Chronic Schizophrenia?
por: Hintze, Beata, et al.
Publicado: (2022)

Differences of resting fMRI and cognitive function between drug-naïve bipolar disorder and schizophrenia
por: Liang, Jiaquan, et al.
Publicado: (2022)

The contribution of the cingulate cortex: treating depressive symptoms in first-episode drug naïve schizophrenia
por: Shen, Haoran, et al.
Publicado: (2023)

Structural abnormalities of cingulate cortex in patients with first‐episode drug‐naïve schizophrenia comorbid with depressive symptoms
por: Wei, Gao‐Xia, et al.
Publicado: (2020)

The Relationship Between Abnormal Resting-State Functional Connectivity of the Left Superior Frontal Gyrus and Cognitive Impairments in Youth-Onset Drug-Naïve Schizophrenia
por: Qiu, Xiaolei, et al.
Publicado: (2021)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

A polydiagnostic approach to cognitive deficits in schizophrenia
por: Sánchez-Torres, A., et al.
Publicado: (2021)

Total antioxidant capacity of the Korean diet
por: Han, Jeong-Hwa, et al.
Publicado: (2014)

Effects of xenobiotics on total antioxidant capacity
por: Ferrari, Carlos Kusano Bucalen
Publicado: (2012)

Cognitive Deficit and Aberrant Intrinsic Brain Functional Network in Early-Stage Drug-Naive Parkinson’s Disease
por: Zhang, Lan, et al.
Publicado: (2022)

Orbitofrontal Lobe Volume Deficits in Antipsychotic-Naïve Schizophrenia: A 3-Tesla MRI study
por: Behere, Rishikesh V., et al.
Publicado: (2009)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
por: Yan, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8vtuovc05164qm13nikle515jk